Literature DB >> 16948799

Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.

I F Metzger1, J T C Sertorio, J E Tanus-Santos.   

Abstract

AIM: Nitric oxide (NO) is an endogenous mediator of many physiological processes, many of which are mediated by cyclic guanosine 3',5'-monophosphate (cGMP). Much effort has been made to validate clinical markers of NO production or bioavailability. While the measurement of plasma nitrate, nitrite, and cGMP concentrations have been suggested to reflect endogenous production of NO, there is no study showing whether there is correlation between these three markers. In the present study, we investigate whether there is correlation between the plasma concentrations of nitrate, nitrite, and cGMP in a relatively homogeneous group of 141 healthy subjects.
METHODS: Venous blood samples were collected from healthy male subjects and plasma aliquots were then immediately removed and stored at -70 degrees C until analysed in duplicate for their nitrite and nitrate content using ozone-based chemiluminescence assays. Plasma cGMP levels were determined by using a commercial enzyme immunoassay.
RESULTS: While we found no significant correlation between plasma nitrite and nitrate concentrations (P = 0.747), or between plasma nitrate and cGMP concentrations (P = 0.221), a significant positive correlation was found between plasma cGMP and nitrite concentrations (P = 0.017, r(s) = 0.270).
CONCLUSIONS: The significant correlation we found between plasma nitrite and cGMP concentrations is consistent with the notion that nitrite or cGMP concentrations in plasma may be useful clinical markers of NO formation in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16948799     DOI: 10.1111/j.1748-1716.2006.01612.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  20 in total

1.  Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.

Authors:  Ingrid F Metzger; Valéria C Sandrim; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Human brain blood flow and metabolism during isocapnic hyperoxia: the role of reactive oxygen species.

Authors:  João D Mattos; Monique O Campos; Marcos P Rocha; Daniel E Mansur; Helena N M Rocha; Vinicius P Garcia; Gabriel Batista; Thiago S Alvares; Gustavo V Oliveira; Mônica V Souza; Rogério L R Videira; Natalia G Rocha; Niels H Secher; Antonio C L Nóbrega; Igor A Fernandes
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

3.  Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension.

Authors:  Marcelo F Montenegro; Lucas C Pinheiro; Jefferson H Amaral; Diogo M O Marçal; Ana C T Palei; Antonio J Costa-Filho; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-20       Impact factor: 3.000

4.  Modulation of penile erection in rabbits by Mondia whitei: possible mechanism of action.

Authors:  O Quasie; O N K Martey; A K Nyarko; W S K Gbewonyo; L K N Okine
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-04-03

5.  Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers.

Authors:  Pamela S Silva; Vanessa Fontana; Ana C T Palei; Jonas T C Sertório; Celso Biagi; Jose Eduardo Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2011-02-09       Impact factor: 2.953

6.  Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.

Authors:  Marcelo F Montenegro; Evandro M Neto-Neves; Carlos A Dias-Junior; Carla S Ceron; Michele M Castro; Valeria A Gomes; Alexandre Kanashiro; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-08       Impact factor: 3.000

7.  Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension.

Authors:  Marcelo F Montenegro; Lucas C Pinheiro; Jefferson H Amaral; Graziele C Ferreira; Rafael L Portella; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06       Impact factor: 3.000

8.  Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction.

Authors:  Jaqueline J Muniz; Riccardo Lacchini; Jonas T C Sertório; Alceu A Jordão; Yuri T D A Nobre; Silvio Tucci; Antônio C P Martins; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-19       Impact factor: 3.000

9.  The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents.

Authors:  J A de Miranda; R Lacchini; V A Belo; C M M Lanna; J T Sertorio; M R Luizon; J E Tanus-Santos
Journal:  J Hum Hypertens       Date:  2014-06-19       Impact factor: 3.012

10.  Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.

Authors:  David Z I Cherney; Heather N Reich; Shan Jiang; Ronnie Har; Rania Nasrallah; Richard L Hébert; Vesta Lai; James W Scholey; Etienne B Sochett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-01       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.